Original language | English |
---|---|
Pages (from-to) | S708 |
Number of pages | 1 |
Journal | European Journal of Cancer |
Volume | 51 |
Issue number | Supplement 3 |
DOIs | |
Publication status | Published - Sep 2015 |
Externally published | Yes |
Event | European Cancer Congress - Vienna, Austria Duration: 25 Sep 2015 → 29 Sep 2015 |
CheckMate 025: a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)
P. Sharma, B. Escudier, D. F. McDermott, S. George, H. J. Hammers, S. Srinivas, S. S. Tykodi, J. A. Sosman, G. Procopio, E. R. Plimack, D. Castellano, H. Gurney, F. Donskov, P. Bono, J. Wagstaff, T. C. Gauler, T. Ueda, L. A. Xu, I. M. Waxman, R. J. Motzer
Research output: Contribution to journal › Meeting abstract